Suppr超能文献

自身免疫性甲状腺炎伴严重甲状腺功能减退,对高口服剂量甲状腺素治疗耐药:病例报告。

Autoimmune thyroiditis with severe hypothyroidism resistant to the treatment with high peroral doses of thyroxine: case report.

作者信息

Payer J, Sladekova K, Kinova S, Cesnakova Z, Killinger Z, Krizko M, Klimes I, Langer P

机构信息

First Clinic of Internal Medicine, Faculty of Medicine, Comenius University, 813 69 Bratislava, Slovakia.

出版信息

Endocr Regul. 2000 Dec;34(4):189-93.

Abstract

Female patient (42 yr) suffered from autoimmune thyroiditis resulting in severe hypothyroidism. She was treated for several years by district physician with the dose of 150 microg L-thyroxine daily. Since the level of TSH was repeatedly very high and no improvement of clinical signs has been observed, she was referred to the Medical Faculty Hospital. Thyroid ultrasound showed remarkable diffuse hypoechogenicity, thyroid scintigraphy showed enlarged thyroid with low 99mTc uptake, TRH test was normal, thin needle biopsy supported autoimmune thyroiditis. X-ray examination showed normal sella turcica and no changes in the pituitary were observed with computer tomography. In spite of increasing the dose of peroral L-thyroxine to 300 microg/d and later to 500 microg/d the clinical status and TSH level did not improve. The patient was originally suspected from malabsorption of thyroxine. However, the test with a large single peroral dose (1000 microg) of L-thyroxine showed a rapid decrease of TSH level (from 126 to 75 mU/l) and increase of total T4 level (from 18 to 64 nmol/l) within 4 hr. Later the patient has been treated with intravenous L-thyroxine (500 microg every 3-4 days for 4 weeks) which resulted in the decrease of TSH level to 10 mU/l and increase of T4 level to 80-100 nmol/l. After that it was concluded that the problem is a poor compliance of the patient who apparently does not actually take the medication, although she always claimed that she is doing so. Referring to some similar cases described in the literature the case was classified as thyroxine pseudomalabsorption. In spite that this problem has been explained to her and her relatives, she refused to take any medication and is consistently neglecting all invitations to further examinations.

摘要

一名42岁女性患者患有自身免疫性甲状腺炎,导致严重甲状腺功能减退。她在当地医生处接受了数年治疗,每日服用150微克左甲状腺素。由于促甲状腺激素(TSH)水平反复很高,且未观察到临床症状改善,她被转诊至医学院附属医院。甲状腺超声显示明显的弥漫性低回声,甲状腺闪烁显像显示甲状腺肿大且99m锝摄取率低,促甲状腺激素释放激素(TRH)试验正常,细针穿刺活检支持自身免疫性甲状腺炎。X线检查显示蝶鞍正常,计算机断层扫描未观察到垂体有变化。尽管将口服左甲状腺素剂量增加至300微克/天,后来又增至500微克/天,但临床状况和TSH水平仍未改善。患者最初被怀疑存在甲状腺素吸收不良。然而单剂量口服大剂量(1000微克)左甲状腺素试验显示,4小时内TSH水平迅速下降(从126降至75 mU/L),总T4水平升高(从18升至64 nmol/L)。后来患者接受静脉注射左甲状腺素治疗(每3 - 4天500微克,共4周),TSH水平降至10 mU/L,T4水平升至80 - 100 nmol/L。此后得出结论,问题在于患者依从性差,尽管她一直声称按医嘱服药,但显然实际上并未服药。参考文献中描述的一些类似病例,该病例被归类为甲状腺素假性吸收不良。尽管已向她及其亲属解释了这个问题,但她拒绝服药,一直无视所有进一步检查的邀请。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验